DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
DexCom
DXCM
Hutchmed (China)
HCM
New Fortress Energy
NFE
Enerpac Tool
EPAC
US Stock MarketDetailed Quotes
GELS Gelteq
- 2.105
- -0.105-4.75%
Close Feb 14 16:00 ET
- 2.105
- 0.0000.00%
Post 20:01 ET
19.87MMarket Cap-8.81P/E (TTM)
2.380High2.050Low22.23KVolume2.270Open2.210Pre Close47.31KTurnover0.73%Turnover RatioLossP/E (Static)9.44MShares5.50052wk High2.07P/B6.42MFloat Cap1.42052wk Low--Dividend TTM3.05MShs Float5.500Historical High--Div YieldTTM14.93%Amplitude1.420Historical Low2.128Avg Price1Lot Size
About Gelteq Company
Gelteq Ltd. is a biotechnology company. It focuses on the development and commercialization of white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, and other products. The firm also offers edible gels. The company was founded by Nathan J. Givoni and Simon H. Szewach on October 15, 2018 and is headquartered in Melbourne, Australia.
Company Profile
SymbolGELS
Company NameGelteq
Listing DateOct 29, 2024
Issue Price4.00
Founded2017
CEOMr. Nathan J. Givoni
MarketNASDAQ
Employees20
Fiscal Year Ends06-30
Address100 Albert Road,Level 4
CitySouth Melbourne
ProvinceVictoria (VIC)
CountryAustralia
Zip Code3025
Phone61-3-9087-3990
Websitehttp://www.gelteq.com
Company Executives
- Name
- Position
- Salary
- Nathan J. Givoni
- Director and Chief Executive Officer
- --
- Anthony W. Panther
- Chief Financial Officer and Principal Accounting Officer
- --
- Simon H. Szewach
- Executive Chairman of the Board
- --
- Jeffrey W. Olyniec
- Independent Director
- --
- The Honourable Philip A. Dalidakis
- Independent Director
- --
- Professor David Morton
- Independent Director
- --
